Design, synthesis and in vitro activity of glycinamide-bearing compounds as DPP-IV inhibitors

Yaoxue Xuebao

Volumn 45, Issue 11, 2010, Pages 1379-1384

  Han, Bei ^a   Huan, Yi ^a   Lin, Zi Yun ^a   Li, Peng ^a   Shen, Zhu Fang ^a   Yin, Da Li ^a   Huang, Hai Hong ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Dipeptidyl peptidase IV inhibitor; Glycinamide; Structure activity relationship; Synthesis

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLYCINAMIDE; SAXAGLIPTIN; VILDAGLIPTIN;

ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; DRUG DESIGN; GLYCINE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PIPERAZINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78651253664     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Havale SH, Pal M. Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes [J]. Bioorg Med Chem, 2009, 17: 1783-1802.
2. Edmondson SD, Mastracchio A, Duffy JL, et al. Discovery of potent and selective orally bioavailable β-substituted phenylalanine derived dipeptidyl peptidase IV inhibitors [J]. Bioorg Med Chem Lett, 2005, 15: 3048-3052.
3. Gu W, Nie AH, Li S. Research development on DPP-IV's targeting T2DM drugs [J]. Chin J Med Chem 2004, 14: 373-378.
4. Benbow JW, Andrews KA, Aubrecht J, et al. Piperidinyl-2-phenethylamino inhibitors of DPP-IV for the treatment of type 2 diabetes [J]. Bioorg Med Chem Lett, 2009, 19: 2220-2223.
5. Madar DJ, Kopecka H, Pireh D, et al. Discovery of 2-[4-[[2-(2S, 5R)-2-cyano-5-ethynyl-1-pyrrolidinyl]-2-oxoethyl] amino]-4-memyl-1-piperidinyl]- 4-pyridinecarboxylic acid (ABT-279): a very potent, selective, effective, and well-tolerated inhibitor of dipeptidyl peptidase-IV, useful for the treatment of diabetes [J]. J Med Chem, 2006, 49: 6416-6420.
6. Sakashita H, Akahoshi F, Kitajima H, et al. [(S)-γ-(Arylamino) prolyl]thiazolidine compounds as a novel series of potent and stable DPP-IV inhibitors [J]. Bioorg Med Chem, 2006, 14: 3662-3671.
7. Parmee ER, He JF, Mastracchio A, et al. 4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors [J]. Bioorg Med Chem Lett, 2004, 14: 43-46. (Pubitemid 38016208)
8. Belyakov S, Hamilton GS, Li WX, et al. Change inhibitors of dipeptidyl peptidase IV: WO, 03057144 [P]. 2003-07-17.
9. Hulin B, Hoover DJ, Treadway JL, et al. Substituted N- (indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors: WO, 9639384 [P]. 1996-12-12.
10. Brandl T, Fu JP, Lenoir F, et al. Organic compounds and their uses: WO, 2007133865 [P]. 2007-11-22.
11. Butlin RJ, Currie GS, Gaskin H, et al. Inhibitors of dipeptidyl peptidase IV: WO, 2005040095 [P]. 2005-05-06.
12. Tsubotani S, Takizawa M, Shirasaki M, et al. Aziridine derivatives, their production and use: WO, 9528416 [P]. 1995-10-26.
13. Meier P, Muller S. Simultaneous deprotection and purification based on ionic resin capture: application to amide formations and grignard and mitsunobu reactions [J]. Synthesis, 2007, 14: 2203-2207. (Pubitemid 47122982)
14. Castro AC, Depew KM, Grogan MJ, et al. Compounds and methods for inhibiting the interaction of BCL proteins with binding partners: WO, 2008024337 [P]. 2008-02-28.
15. Corringer PJ, Weng JH, Ducos B, et al. CCK-B agonist or antagonist activities of structurally hindered and peptidase-resistant Boc-CCK4 derivatives [J]. J Med Chem, 1993, 36: 166-172. (Pubitemid 23040159)
16. Hu CX, Huang H, Zhang L, et al. A new screening method based on yeast-expressed human dipeptidyl peptidase IV and discovery of novel inhibitors [J]. Biotech Lett, 2009, 31: 979-984.